Top 5 Life Science Startup Investors in Portugal (June 2026)

Caixa Capital is the Private Equity and Venture Capital arm of banking Group Caixa Geral de Depósitos and has a track record spanning over two decades of activity, since the industry was created in Portugal. It is a leading investor in terms of funds under management, portfolio size and diversity.Caixa Capital´s mission is to invest in fundsand companies, led by highly qualified management teams, with high growth and valuation potential, that enable our funds to achieve an attractive risk adjusted return and for society at large to benefit sustainably from our activity.Currently with more than 700 million Euros under management and a portfolio of over 80 investments, Caixa Capital is a reference in this area with special links to the respective European sector associations.

Investment focus

Industry: Software, Information Technology, SaaS
Stage:Seed, Series A
Geography: Portugal, United States, Spain

Investor stats

Total investments: 67
Round size: Seed $120k–$2.5M; Series A $3M–$12M
Lead/follow: 16% lead, 84% follow

Portfolio highlights

BioMimetx — BioMimetx is a biotech startup focused on the development of green antifouling solutions to prevent marine biofouling. The company discovers and owns environmental bacteria that secrete molecules, which are used as natural antimicrobials and algaecides. BioMimetx is based in Cantanhede, Portugal.
Movvo — The Movvo platform delivers smart business intelligence solutions for owners and operators of retail and commercial real estate that turns data into improved retail performance and better value engineering decisions. The platform combines consumer behaviour wireless sensor technology and digests other public and private datasets, enhancing theunderstanding of the data by applying machine learning to provide fast and easy interpretation of this data delivering insights and rapid scenario-planning. Whether it is measuring ROI or reporting KPI's, the Movvo platform has these bases covered. Where it comes into its own is via the application of machine learning Want to easily prepare a leasing pack that maximises the rental value, what to create additional incremental value from asset investment decisions, want to know the impact of changing the tenant from apparel retailer to food & beverage? The Movvo platform can deliver prescriptive intelligence and more.
Exogenus Therapeutics — Exogenus Therapeutics is engineering cell biology for innovative therapeutic solutions.Exo-T is a biotechnology company dedicated to the pre-clinical and clinical development of innovative cellular-based therapies applied to regenerative medicine, specifically for the skin lesions treatment. The company is presently developing its first product,Exo-Wound, for the treatment of chronic wounds.The project that led to the creation of the company (Nanoinspire) participated in COHiTEC 2014 program and is the result of the research developed in collaboration with Crioestaminal SA, Biocant, and Centre for Neurosciences and Cellular Biology of Coimbra University.

Show all investments...

SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.

Investment focus

Industry: Biotechnology, Health Care, Software
Stage:Seed, Convertible Note, Pre-Seed
Geography: United States, India, United Kingdom

Investor stats

Total investments: 1482
Lead/follow: no public data

Portfolio highlights

MixRift — MIXRIFT - game developers specialized in Mixed Reality
unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.

Show all investments...

Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004,Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.

Investment focus

Industry: Software, Artificial Intelligence, Health Care
Stage:Seed, Series A, Pre-Seed
Geography: Australia, United States, Hong Kong

Investor stats

Total investments: 227
Round size: Seed $120k–$5M; Pre-Seed $40k–$1.5M; Series A $2.3M–$15M
Lead/follow: 34% lead, 66% follow
Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

CUZIN — Providing a surprisingly human shopping experience. Trusted and secure. Millions of domains to choose from.
Andromeda Robotics — At Andromeda, our personalised robot companions are helping Australian aged care teams bring joy and connection to residents to improve wellbeing.
Infiction labs — SPARC 1.2 is a solar panel robotic cleaning system designed and developed by Infiction Labs Pvt Ltd for commercial solar plants.

Show all investments...

SIF provides financial support for public charities & acts as a fiscal agent for charities and foundations.

Investment focus

Industry: Apps, Video, Finance
Stage:Seed, Debt Financing
Geography: Spain, Portugal, United States

Investor stats

Total investments: 4
Round size: Seed $942k–$2.5M
Lead/follow: 50% lead, 50% follow

Portfolio highlights

Criam — CRIAM stands for Chemical Reaction and Image Analysis for Mobility. We are a Medtech startup born in January 2016 focused in the Point-of-Care diagnostic segment. Our mission is to provide fast, affordable and in-situ blood test analysis to empower people with instant information about their well-being and health conditions. With our device as aplatform approach we will be able to monitor, control and contain diseases worldwide.
tuTECHÔ — tuTECHÔ is an innovative social enterprise born with the purpose of contributing to the eradication of homelessness in Spain.
MemoryWell — MemoryWell is a digital platform for storytelling that brings the skills of professional writers to the challenge of helping elders tell their life story. With MemoryWell+, you can build a collaborative timeline around that story, adding photos, videos, letters and documents. Everyone has a story, let us help you capture it.

Show all investments...